‘Milestone’ ovarian cancer drug which can extend life expectancy licensed for use in the UK

‘Milestone’ ovarian cancer drug which can extend life expectancy licensed for use in the UK

This article was taken from: http://www.independent.co.uk/news/health/milestone-ovarian-cancer-drug-approved-uk-chemotherapy-treatment-a8115101.html By: Alex Matthews-King Health Correspondent  Once-a-day pill gives women an extra year and a half before the disease returns A pill which has the potential to buy an extra 16 months of life for women with ovarian cancer has been dubbed a “milestone” treatment, after it was licensed for use in the UK. The once-daily pill Niraparib is…